top of page
  • Rick

FDA Alert of Dental Complications

As of January 10th, 2022, the FDA has issued a warning that "dental problems" could result from the use of buprenorphine medicines dissolved intra-orally. If you have patients with a history of opioid abuse, transmucosal use of buprenorphine can affect their oral health and should enter into your treatment plans.

For further information, see the drug-use guide on the FDA's web site or view the entire FDA alert here.


Recent Posts

See All

Arm Yourself with the Power of Knowledge

Infection control has been receiving a lot of extra attention of late, but it has always been a concern in dental offices. There have...

Is This an OSHA Violation?

A discussion of what agency covers what regulations. Helping navigate the various federal agencies.


bottom of page